Table of Contents Author Guidelines Submit a Manuscript
Journal of Transplantation
Volume 2009, Article ID 357093, 4 pages
http://dx.doi.org/10.1155/2009/357093
Research Article

The Use of Imatinib Mesylate as a Lifesaving Treatment of Chronic Myeloid Leukemia Relapse after Bone Marrow Transplantation

1Disciplina de Hematologia, da Faculdade de Medicina, da Universidade de São Paulo, 05403-000 São Paulo, Brazil
2Laboratorio de Cytogenetica, da Disciplina de Hematologia, da Faculdade de Medicina, da Universidade de São Paulo, 05403-000 São Paulo, Brazil
3Fundação Pro-Sangue/ Hemocentro de São Paulo, 05403-000 São Paulo, Brazil

Received 2 July 2009; Accepted 14 August 2009

Academic Editor: Kazuhiko Yamada

Copyright © 2009 Monika Conchon et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Monika Conchon, Sabri S. Sanabani, Israel Bendit, et al., “The Use of Imatinib Mesylate as a Lifesaving Treatment of Chronic Myeloid Leukemia Relapse after Bone Marrow Transplantation,” Journal of Transplantation, vol. 2009, Article ID 357093, 4 pages, 2009. https://doi.org/10.1155/2009/357093.